TUDOR INVESTMENT CORP ET AL - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 52 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q2 2021$93,000
-78.1%
13,991
-47.2%
0.00%
-90.5%
Q2 2020$425,000
+59.2%
26,513
-40.5%
0.02%
-12.5%
Q1 2020$267,00044,5590.02%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$15,723,00027.32%
TFG Asset Management GP Ltd 3,039,381$6,504,0000.78%
Nantahala Capital Management 5,215,788$11,162,0000.72%
Frazier Life Sciences Management, L.P. 3,746,857$8,018,0000.62%
HARBOR CAPITAL ADVISORS, INC. 148,454$318,0000.29%
DAFNA Capital Management LLC 496,150$1,062,0000.29%
Blackstone Inc. 17,985,611$38,4890.14%
Ikarian Capital, LLC 260,087$556,0000.11%
MYDA Advisors LLC 100,000$214,0000.10%
Privium Fund Management B.V. 113,528$253,0000.09%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders